Cargando…
Heterogeneous Klebsiella pneumoniae Co-infections Complicate Personalized Bacteriophage Therapy
Multidrug-resistant (MDR) organisms have increased worldwide, posing a major challenge for the clinical management of infection. Bacteriophage is expected as potential effective therapeutic agents for difficult-to-treat infections. When performing bacteriophage therapy, the susceptibility of lytic b...
Autores principales: | Qin, Jinhong, Wu, Nannan, Bao, Juan, Shi, Xin, Ou, Hongyu, Ye, Shanke, Zhao, Wei, Wei, Zhenquan, Cai, Jinfeng, Li, Lisha, Guo, Mingquan, Weng, Jingyan, Lu, Hongzhou, Tan, Demeng, Zhang, Jianzhong, Huang, Qin, Zhu, Zhaoqin, Shi, Yejing, Hu, Chunlan, Guo, Xiaokui, Zhu, Tongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868542/ https://www.ncbi.nlm.nih.gov/pubmed/33569355 http://dx.doi.org/10.3389/fcimb.2020.608402 |
Ejemplares similares
-
A Frameshift Mutation in wcaJ Associated with Phage Resistance in Klebsiella pneumoniae
por: Tan, Demeng, et al.
Publicado: (2020) -
Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae
por: Bao, Juan, et al.
Publicado: (2020) -
Characterization of Klebsiella pneumoniae ST11 Isolates and Their Interactions with Lytic Phages
por: Tan, Demeng, et al.
Publicado: (2019) -
Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients
por: Wu, Nannan, et al.
Publicado: (2021) -
Characterization of Pseudomonas aeruginosa Bacteriophage L5 Which Requires Type IV Pili for Infection
por: Yang, Lan, et al.
Publicado: (2022)